288. Autoimmune acquired coagulation factor deficiency Clinical trials / Disease details
Clinical trials : 206 / Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2006-002857-54-DE (EUCTR) | 10/11/2006 | 10/08/2006 | International clinical study to investigate the efficacy and safety of Wiloctin in patients with inherited von willebrand disease (vWD) | International clinical study to investigate the efficacy and safety of Wiloctin in patients with inherited von willebrand disease (vWD) | von Willebrand Jürgends syndrom in children under 6 years of age | Trade Name: WILATE Product Name: Wiloctin | Octapharma AG | NULL | Not Recruiting | Female: yes Male: yes | 50 | Germany |